SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-018659
Filing Date
2018-08-02
Accepted
2018-08-02 07:01:35
Documents
57
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-10q_20180630.htm 10-Q 1010665
2 EX-10.2 nerv-ex102_88.htm EX-10.2 19879
3 EX-31.1 nerv-ex311_7.htm EX-31.1 16942
4 EX-31.2 nerv-ex312_8.htm EX-31.2 16746
5 EX-32.1 nerv-ex321_6.htm EX-32.1 9535
  Complete submission text file 0001564590-18-018659.txt   4765092

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nerv-20180630.xml EX-101.INS 933594
7 XBRL TAXONOMY EXTENSION SCHEMA nerv-20180630.xsd EX-101.SCH 44622
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20180630_cal.xml EX-101.CAL 35490
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20180630_def.xml EX-101.DEF 181806
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20180630_lab.xml EX-101.LAB 366346
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20180630_pre.xml EX-101.PRE 291628
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 18986606
SIC: 2834 Pharmaceutical Preparations